Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. Currently, Gen9 offers multiple synthetic biology solutions for researchers who need high quality clonal, sequence-perfect DNA. Our award winning BioFab® process is remarkably flexible and very high throughput; allowing us to make the genes you need quickly at the highest quality available. Gen9 is Powering the Synthetic Biology Revolution.

Type
Private
HQ
Cambridge, US
Founded
2009
Employees
43 (est)
Gen9 was founded in 2009 and is headquartered in Cambridge, US

Gen9 Locations

Cambridge, US

Gen9 Metrics

Gen9 Summary

Founding Date

2009

Total Funding

$50.1 M

Latest funding size

$25 M

Time since last funding

over 2 years

Investors

Gen9's latest funding round of $25 M was in July 2014. In total, Gen9 has raised $50.1 M.
12% of current employees of Gen9 are female and 88% are male.

Gen9 Company Life